Aspen Aerogels to Announce Q4/FY23 Results Feb 29

TL;DR

**Aspen Aerogels is dropping Q4/FY23 earnings on Feb 29th, get ready for potential stock moves.**

AI Summary

Aspen Aerogels, Inc. filed an 8-K on February 12, 2024, to announce that it will be releasing its financial results for the fourth quarter and full year ended December 31, 2023, after the market closes on Thursday, February 29, 2024. The company will also host a conference call and webcast at 5:00 p.m. ET on the same day to discuss these results. This matters to investors because it provides a specific date to expect crucial financial performance updates, which can significantly impact the stock price.

Why It Matters

This filing sets the date for Aspen Aerogels to release its latest financial performance, which is critical for investors to assess the company's health and future prospects.

Risk Assessment

Risk Level: low — This filing is purely informational, announcing an upcoming earnings release, and does not contain any immediate financial risks.

Analyst Insight

A smart investor would mark February 29, 2024, on their calendar to review Aspen Aerogels' Q4 and full-year 2023 financial results and listen to the conference call for insights into future performance and guidance.

Key Players & Entities

• ASPEN AEROGELS, INC. (company) — the registrant filing the 8-K
• February 12, 2024 (date) — date of earliest event reported
• February 29, 2024 (date) — date of Q4 and full year 2023 earnings release and conference call
• 5:00 p.m. ET (time) — start time of the conference call and webcast
• The New York Stock Exchange (company) — exchange where Aspen Aerogels' Common Stock (ASPN) is registered

FAQ

Filing Documents

• aspn-20240212.htm (8-K) — 44KB
• aspn-ex99_1.htm (EX-99.1) — 317KB
• 0000950170-24-013840.txt ( ) — 491KB
• aspn-20240212.xsd (EX-101.SCH) — 24KB
• aspn-20240212_htm.xml (XML) — 5KB

02 Results of Operations and Financial Condition

Item 2.02 Results of Operations and Financial Condition. On February 12, 2024, Aspen Aerogels, Inc. announced its financial results for the fourth quarter and fiscal year 2023, which ended December 31, 2023, and also discussed business developments. A copy of the press release containing such announcement is attached hereto as Exhibit 99.1. The information set forth in the press release, except for the information set forth under the heading "2024 Financial Outlook" and under the heading "About Aspen Aerogels, Inc.," together with the forward-looking statement disclaimer at the end of the press release, is incorporated by reference into this Item 2.02 of this Current Report on Form 8-K.

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. The information set forth under the heading "2024 Financial Outlook" and under the heading "About Aspen Aerogels, Inc.," together with the forward-looking statement disclaimer at the end of the press release, is incorporated by reference into this Item 7.01 of this Current Report on Form 8-K.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release issued by Aspen Aerogels, Inc. on February 12, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) The press release may contain hypertext links to information on our website. The information on our website is not incorporated by reference into this Current Report on Form 8-K and does not constitute a part of this Form 8-K. The information contained in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities under that Section, nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Aspen Aerogels, Inc. Date: February 12, 2024 By: /s/ Ricardo C. Rodriguez Name: Ricardo C. Rodriguez Title: Chief Financial Officer and Treasurer

View Full Filing

View this 8-K filing on SEC EDGAR